Literature DB >> 26792858

AP-1 Is a Key Regulator of Proinflammatory Cytokine TNFα-mediated Triple-negative Breast Cancer Progression.

Yichun Qiao1, Huan He1, Philip Jonsson2, Indranil Sinha1, Chunyan Zhao3, Karin Dahlman-Wright4.   

Abstract

Triple-negative breast cancer (TNBC) represents a highly aggressive form of breast cancer with limited treatment options. Proinflammatory cytokines such as TNFα can facilitate tumor progression and metastasis. However, the mechanistic aspects of inflammation mediated TNBC progression remain unclear. Using ChIP-seq, we demonstrate that the cistrome for the AP-1 transcription factor c-Jun is comprised of 13,800 binding regions in TNFα-stimulated TNBC cells. In addition, we show that c-Jun regulates nearly a third of the TNFα-regulated transcriptome. Interestingly, high expression level of the c-Jun-regulated pro-invasion gene program is associated with poor clinical outcome in TNBCs. We further demonstrate that c-Jun drives TNFα-mediated increase of malignant characteristics of TNBC cells by transcriptional regulation of Ninj1. As exemplified by the CXC chemokine genes clustered on chromosome 4, we demonstrate that NF-κB might be a pioneer factor required for the regulation of TNFα-inducible inflammatory genes, whereas c-Jun has little effect. Together, our results uncover AP-1 as an important determinant for inflammation-induced cancer progression, rather than inflammatory response.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  AP1 transcription factor (AP-1); ChIP-sequencing (ChIP-seq); breast cancer; gene expression; tumor necrosis factor (TNF)

Mesh:

Substances:

Year:  2016        PMID: 26792858      PMCID: PMC4777842          DOI: 10.1074/jbc.M115.702571

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  The Activation of IL-1-Induced Enhancers Depends on TAK1 Kinase Activity and NF-κB p65.

Authors:  Liane Jurida; Johanna Soelch; Marek Bartkuhn; Katja Handschick; Helmut Müller; Doris Newel; Axel Weber; Oliver Dittrich-Breiholz; Heike Schneider; Sabin Bhuju; Vera V Saul; M Lienhard Schmitz; Michael Kracht
Journal:  Cell Rep       Date:  2015-02-05       Impact factor: 9.423

Review 2.  Estrogen receptor beta in breast cancer.

Authors:  Lars-Arne Haldosén; Chunyan Zhao; Karin Dahlman-Wright
Journal:  Mol Cell Endocrinol       Date:  2013-08-15       Impact factor: 4.102

3.  Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis.

Authors:  Konrad Hochedlinger; Erwin F Wagner; Kanaga Sabapathy
Journal:  Oncogene       Date:  2002-04-04       Impact factor: 9.867

Review 4.  Inflammation meets cancer, with NF-κB as the matchmaker.

Authors:  Yinon Ben-Neriah; Michael Karin
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

5.  Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.

Authors:  M Shiohara; M I Dawson; P D Hobbs; N Sawai; T Higuchi; K Koike; A Komiyama; H P Koeffler
Journal:  Blood       Date:  1999-03-15       Impact factor: 22.113

Review 6.  Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Authors:  Lisa M Coussens; Laurence Zitvogel; A Karolina Palucka
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

Review 7.  Matrix metalloproteinase (MMP)-9: a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation.

Authors:  Ganesh V Halade; Yu-Fang Jin; Merry L Lindsey
Journal:  Pharmacol Ther       Date:  2013-04-03       Impact factor: 12.310

8.  Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer.

Authors:  Chunyan Zhao; Yichun Qiao; Philip Jonsson; Jian Wang; Li Xu; Pegah Rouhi; Indranil Sinha; Yihai Cao; Cecilia Williams; Karin Dahlman-Wright
Journal:  Cancer Res       Date:  2014-05-15       Impact factor: 12.701

Review 9.  Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?

Authors:  Fanny Le Du; Bedrich L Eckhardt; Bora Lim; Jennifer K Litton; Stacy Moulder; Funda Meric-Bernstam; Ana M Gonzalez-Angulo; Naoto T Ueno
Journal:  Oncotarget       Date:  2015-05-30

10.  AP-1-mediated chromatin looping regulates ZEB2 transcription: new insights into TNFα-induced epithelial-mesenchymal transition in triple-negative breast cancer.

Authors:  Yichun Qiao; Chiou-Nan Shiue; Jian Zhu; Ting Zhuang; Philip Jonsson; Anthony P H Wright; Chunyan Zhao; Karin Dahlman-Wright
Journal:  Oncotarget       Date:  2015-04-10
View more
  34 in total

1.  Metformin induces the AP-1 transcription factor network in normal dermal fibroblasts.

Authors:  Zoe E Gillespie; Chenxuan Wang; Flaviu Vadan; Topaza Y Yu; Juan Ausió; Anthony Kusalik; Christopher H Eskiw
Journal:  Sci Rep       Date:  2019-03-29       Impact factor: 4.379

2.  Integrative network-based approach identifies central genetic and transcriptomic elements in triple-negative breast cancer.

Authors:  Ramireddy Sriroopreddy; C Sudandiradoss
Journal:  Funct Integr Genomics       Date:  2017-12-19       Impact factor: 3.410

3.  JUN promotes hypertrophic skin scarring via CD36 in preclinical in vitro and in vivo models.

Authors:  Michelle F Griffin; Mimi R Borrelli; Julia T Garcia; Michael Januszyk; Megan King; Tristan Lerbs; Lu Cui; Alessandra L Moore; Abra H Shen; Shamik Mascharak; Nestor M Diaz Deleon; Sandeep Adem; Walter L Taylor; Heather E desJardins-Park; Marc Gastou; Ronak A Patel; Bryan A Duoto; Jan Sokol; Yuning Wei; Deshka Foster; Kellen Chen; Derrick C Wan; Geoffrey C Gurtner; Hermann P Lorenz; Howard Y Chang; Gerlinde Wernig; Michael T Longaker
Journal:  Sci Transl Med       Date:  2021-09-01       Impact factor: 17.956

Review 4.  The different facets of heme-oxygenase 1 in innate and adaptive immunity.

Authors:  Rafael Cardoso Maciel Costa Silva; Luiz Ricardo Vasconcelos; Leonardo Holanda Travassos
Journal:  Cell Biochem Biophys       Date:  2022-08-26       Impact factor: 2.989

5.  Identification of the Potential Molecular Mechanisms Linking RUNX1 Activity with Nonalcoholic Fatty Liver Disease, by Means of Systems Biology.

Authors:  Laia Bertran; Ailende Eigbefoh-Addeh; Marta Portillo-Carrasquer; Andrea Barrientos-Riosalido; Jessica Binetti; Carmen Aguilar; Javier Ugarte Chicote; Helena Bartra; Laura Artigas; Mireia Coma; Cristóbal Richart; Teresa Auguet
Journal:  Biomedicines       Date:  2022-06-03

6.  Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5.

Authors:  Benjamin Newcomb; Cosima Rhein; Izolda Mileva; Rasheed Ahmad; Christopher J Clarke; Justin Snider; Lina M Obeid; Yusuf A Hannun
Journal:  J Lipid Res       Date:  2018-05-03       Impact factor: 5.922

7.  TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients.

Authors:  Maya Dadiani; Daniela Necula; Smadar Kahana-Edwin; Nino Oren; Tamir Baram; Irina Marin; Dana Morzaev-Sulzbach; Anya Pavlovski; Nora Balint-Lahat; Liat Anafi; Stefan Wiemann; Cindy Korner; Einav Nili Gal-Yam; Camila Avivi; Bella Kaufman; Iris Barshack; Adit Ben-Baruch
Journal:  Cancer Immunol Immunother       Date:  2020-03-20       Impact factor: 6.968

8.  Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.

Authors:  Chen-Shan Chen Woodcock; Yi Huang; Steven R Woodcock; Sonia R Salvatore; Bhupinder Singh; Franca Golin-Bisello; Nancy E Davidson; Carola A Neumann; Bruce A Freeman; Stacy G Wendell
Journal:  J Biol Chem       Date:  2017-11-20       Impact factor: 5.157

9.  Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas.

Authors:  Xia Liu; Jiaji G Chen; Manit Munshi; Zachary R Hunter; Lian Xu; Amanda Kofides; Nickolas Tsakmaklis; Maria G Demos; Maria Luisa Guerrera; Gloria G Chan; Cristina Jimenez; Christopher J Patterson; Kirsten Meid; Andrew Keezer; Jorge J Castillo; Steven P Treon; Guang Yang
Journal:  Blood Adv       Date:  2020-01-14

10.  Depression, Anxiety, and Social Environmental Adversity as Potential Modulators of the Immune Tumor Microenvironment in Breast Cancer Patients.

Authors:  Eida M Castro-Figueroa; Karina I Acevedo; Cristina I Peña-Vargas; Normarie Torres-Blasco; Idhaliz Flores; Claudia B Colón-Echevarria; Lizette Maldonado; Zindie Rodríguez; Alexandra N Aquino-Acevedo; Heather Jim; María I Lazaro; Guillermo N Armaiz-Peña
Journal:  Med Sci (Basel)       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.